Literature DB >> 7764548

Molecular cloning of a gene, DHS1, which complements a drug-hypersensitive mutation of the yeast Saccharomyces cerevisiae.

Y S Lee1, J Shimizu, K Yoda, M Yamasaki.   

Abstract

We isolated a Saccharomyces cerevisiae mutant, CH108, which shows hypersensitivity to cycloheximide, bleomycin, actinomycin D, 5-fluorouracil, and several other antibiotics. The mutant cells showed irregular shapes with swelling and were also hypersensitive to Zymolyase digestion. The mutant cell wall was swelled and twice as thick as the wild type cell wall. These defects were completely reversed by introduction of a genomic clone on a single-copy vector. Restriction analysis and sequencing showed that the responsible gene, DHS1, encodes a novel hydrophilic polypeptide of 483 amino acids.

Entities:  

Mesh:

Year:  1994        PMID: 7764548     DOI: 10.1271/bbb.58.391

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  3 in total

1.  Identification and characterization of Saccharomyces cerevisiae EXO1, a gene encoding an exonuclease that interacts with MSH2.

Authors:  D X Tishkoff; A L Boerger; P Bertrand; N Filosi; G M Gaida; M F Kane; R D Kolodner
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

2.  Exonuclease I of Saccharomyces cerevisiae functions in mitotic recombination in vivo and in vitro.

Authors:  P Fiorentini; K N Huang; D X Tishkoff; R D Kolodner; L S Symington
Journal:  Mol Cell Biol       Date:  1997-05       Impact factor: 4.272

3.  RNA metabolism is the primary target of formamide in vivo.

Authors:  Rafael Hoyos-Manchado; Félix Reyes-Martín; Charalampos Rallis; Enrique Gamero-Estévez; Pablo Rodríguez-Gómez; Juan Quintero-Blanco; Jürg Bähler; Juan Jiménez; Víctor A Tallada
Journal:  Sci Rep       Date:  2017-11-21       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.